CD4 and cancer: These data highlight a functional difference in the CD4+ T cells in cancer septic vs. previously healthy septic hosts, and suggest at least in some subsets, the upregulation of molecules such as PD-1, 2B4, etc. may be markers of increased immune activation in cancer septic animals.